€23.60
Your prediction
Matthews International Corp. Stock
Pros and Cons of Matthews International Corp. in the next few years
Pros
Cons
Performance of Matthews International Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Matthews International Corp. | -0.840% | 2.609% | 3.509% | 11.954% | 4.889% | -44.601% | -18.621% |
| Vuzix Corp. | 7.390% | 5.330% | -26.030% | 4.869% | -27.912% | -53.487% | -83.707% |
| USANA Health Sciences Inc. | 1.580% | 1.579% | 19.136% | -24.016% | 16.970% | -65.536% | -77.427% |
| Pola Orbis Holdings Inc. | 0.000% | 0.000% | 6.015% | -0.704% | 1.439% | -45.349% | -67.056% |
Comments
News
Eton Pharmaceuticals Q1 Earnings Call Highlights
Eton Pharmaceuticals (NASDAQ:ETON) raised its 2026 revenue outlook after reporting record first-quarter product sales and highlighting early progress from two recent product launches, DESMODA and
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million?
According to its SEC filing dated May 4, 2026, Matthews International Capital Management LLC purchased 242,785 additional shares of Yum China (NYSE:YUMC) in the first quarter.
The estimated value of


